MAGNESIUM SULPHATE VS LIGNOCAINE INTRAVENOUS INFUSION FOR POSTOPERATIVE PAIN RELIEF
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/02/049799
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing elective Laparoscopic Hysterectomy surgery under ASA-PS I&II
Exclusion Criteria
Patient who refused to give informed and written consent
Patients of ASA-PS III%IV
Patients who are allergic to Lignocaine or Magnesium sulfate
Patients on opioid medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative pain assesment by visual analog scale and opioid consumption by the patient in 1st 24Hours of the Post operative periodTimepoint: Immediately after extubation,then Hourly in the first 24Hours
- Secondary Outcome Measures
Name Time Method Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) will be continuously monitored and recorededTimepoint: pre-op (baseline), pre-induction, post-induction and 1, 3, 5, 10 & 15 minutes after intubation and until the end of the surgery